EPIC
FDA Approves Unknown Drug — EPIC PHARMA LLC
EPIC Pharma received FDA approval for Abbreviated New Drug Application ANDA090895, which positions the company to enter the generic market, potentiall...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Lundbeck
FDA Approves SABRIL — Lundbeck Pharmaceuticals LLC
# FDA Approves Lundbeck's SABRIL (Vigabatrin) for Oral Use Lundbeck Pharmaceuticals LLC has received FDA approval for SABRIL (vigabatrin) oral formul...
Amneal
FDA Approves DIGOXIN — Amneal Pharmaceuticals of New York LLC
# FDA Approves Digoxin Generic from Amneal Pharmaceuticals Amneal Pharmaceuticals of New York LLC received FDA approval for its generic digoxin oral ...
AMAG
FDA Approves FERAHEME — AMAG Pharmaceuticals, Inc
# FDA Approves AMAG Pharmaceuticals' FERAHEME for Iron Deficiency Treatment AMAG Pharmaceuticals, Inc. received FDA approval for FERAHEME (ferumoxyto...
Allergan,
FDA Approves OZURDEX — Allergan, Inc.
Allergan, Inc. secured FDA approval for its intravitreal dexamethasone implant OZURDEX on June 17, a move that solidified the company's leadership pos...
Accord
FDA Approves MYCOPHENOLATE MOFETIL — Accord Healthcare Inc.
Accord Healthcare Inc. has announced the addition of Mycophenolate Mofetil—marketed as Myfortic—to its portfolio, providing pharmacists with a B2B500 ...
Par
FDA Approves RISPERIDONE — Par Health USA, LLC
Par Health USA, LLC announced the approval of its Abbreviated New Drug Application for Risperidone on April 30, 2009, which is expected to drive immed...
SUN
FDA Approves Unknown Drug — SUN PHARM INDS INC
# FDA Approves Generic Drug Application for Sun Pharmaceutical Industries Sun Pharmaceutical Industries Inc. received FDA approval for an abbreviated...
Novartis
FDA Approves AFINITOR — Novartis Pharmaceuticals Corporation
# FDA Approves Novartis's Afinitor (Everolimus) for Oncology Treatment Novartis Pharmaceuticals Corporation received FDA approval for Afinitor (evero...
SUN
FDA Approves Unknown Drug — SUN PHARM INDS LTD
# FDA Approves Sun Pharmaceutical's Generic Drug Application Sun Pharmaceutical Industries Ltd. received FDA approval for its abbreviated new drug ap...
Cipla
FDA Approves TOPIRAMATE — Cipla USA Inc.
# FDA Approves Generic Topiramate from Cipla USA Inc. Cipla USA Inc. received FDA approval for its generic topiramate oral formulation on March 27, 2...
Sun
FDA Approves LEUPROLIDE ACETATE — Sun Pharmaceutical Industries, Inc.
# FDA Approves Sun Pharmaceutical's Generic Leuprolide Acetate Sun Pharmaceutical Industries, Inc. received FDA approval for its generic leuprolide a...
Glenmark
FDA Approves LAMOTRIGINE — Glenmark Pharmaceuticals Inc., USA
Glenmark Pharmaceuticals Inc., USA secured final FDA approval for its generic Lamotrigine oral drug, clearing the path for a cost-effective market ent...
Harrow
FDA Approves TOBRADEX ST — Harrow Eye, LLC
# FDA Approves Harrow Eye's TOBRADEX ST for Ophthalmic Inflammation Harrow Eye, LLC has received FDA approval for TOBRADEX ST (tobramycin/dexamethaso...
TARO
FDA Approves Unknown Drug — TARO
# FDA Approves TARO's Generic Drug Application Taro Pharmaceutical Industries has received FDA approval for ANDA 079204, expanding its generic drug p...
SANDOZ
FDA Approves Unknown Drug — SANDOZ
# FDA Approves Sandoz Generic Drug Application Sandoz received FDA approval for ANDA040719 on January 29, 2009, expanding its generic drug portfolio ...
Mylan
FDA Approves DIVALPROEX SODIUM — Mylan Pharmaceuticals Inc.
Mylan Pharmaceuticals Inc. secured FDA approval for its generic Divalproex Sodium, a substance used to treat epilepsy and bipolar disorder, positionin...
RISING
FDA Approves Unknown Drug — RISING
# FDA Approves Rising's Generic Drug Application Rising Pharmaceuticals received FDA approval for its abbreviated new drug application (ANDA077420) o...
Aurobindo
FDA Approves LAMOTRIGINE — Aurobindo Pharma Limited
Aurobindo Pharma Limited secured final FDA approval for its generic Lamotrigine oral tablets, a development anticipated to enhance the company's marke...
Advagen
FDA Approves LAMOTRIGINE — Advagen Pharma Limited
Advagen Pharma Limited announced the FDA approval of its generic oral LAMOTRIGINE formulation under ANDA078625, granting the company immediate access ...